BRD2 and neoplasm: Here, we report that miR-96, miR-182 and miR-183 expression levels are significantly higher in breast cancer compared to the NAT, and the transcription pattern of miR-183/-96/-182 is irregular in breast cancer as the correlation between miR-182 and miR-183 expression dropped dramatically in tumor samples.